To empower participants with a comprehensive understanding of cancer viruses, their role in tumorigenesis, and the emerging strategies for therapeutic intervention.

About Program

This program delves into the fascinating and evolving field of viral oncology. Through a combination of lectures, discussions, and case studies, participants will gain a deeper understanding of how viruses can hijack cellular processes and contribute to cancer initiation and progression.

Show Your Interest Explore More Courses

Program Objectives

Explore the diverse range of viruses implicated in human cancers.
Analyze the mechanisms by which viruses contribute to cancer development.
Discuss the current methods for diagnosing and monitoring viral-associated cancers.
Evaluate the potential of antiviral therapies and vaccines in cancer prevention and treatment.
Explore the burgeoning field of oncolytic virotherapy and its applications.
Identify the ethical considerations surrounding the use of viruses in cancer therapy.

Program Structure

Module 1: Introduction to Viral Oncology
Week 1: Understanding Cancer Viruses

Overview of the history of viral oncology and its significance.
Introduction to oncogenic viruses and their role in cancer development.
Basic concepts of viral oncology, including key terminology and mechanisms.

Week 2: Key Concepts in Virology and Oncology

Detailed exploration of virus biology and cancer cell interactions.
Study of how viral mechanisms contribute to cancer cell transformation.
Examination of fundamental concepts in virology and oncology through interactive diagrams.

Module 2: Major Oncogenic Viruses
Week 3: Human Papillomavirus (HPV) and Cervical Cancer

Pathogenesis of HPV and its link to cervical cancer development.
Review of global health impacts and success stories of the HPV vaccine.
Analysis of screening data to understand trends and effectiveness of HPV prevention strategies.

Week 4: Hepatitis B and C Viruses and Liver Cancer

Overview of hepatocellular carcinoma and its association with hepatitis B and C viruses.
Simulation activities on liver cancer progression and viral interaction dynamics.
Study of hepatitis viruses’ epidemiology and their role in liver cancer.

Week 5: Epstein-Barr Virus (EBV) and Associated Cancers

Examination of EBV and its relationship with lymphomas and other cancers.
Discussion on current research and developments regarding EBV vaccines.
Case studies on EBV, focusing on clinical presentations and epidemiology.

Module 3: Diagnosis and Therapeutic Strategies
Week 6: Diagnostic Tools for Viral-Induced Cancers

Overview of molecular diagnostics used in detecting viral-induced cancers.
Exploration of imaging techniques in the diagnosis of these cancers.
Virtual lab activities demonstrating the use of diagnostic tools in clinical settings.

Week 7: Current Treatments and Emerging Therapies

Study of how antiviral therapies are utilized in cancer treatment.
Discussion of current and emerging therapeutic approaches in treating viral-induced cancers.
Design of treatment plans for hypothetical scenarios involving viral oncology.

Module 4: Research Trends and Future Directions
Week 8: New Frontiers in Viral Oncology Research

Introduction to gene therapy and oncolytic viruses as innovative treatment options.
Exploration of future trends in viral oncology through an interactive timeline.
Study of potential innovations in the research and treatment of viral-induced cancers.

Week 9: Global Impact and Epidemiological Studies

Analysis of the epidemiology of viral cancers worldwide.
Group projects focused on analyzing epidemiological data related to viral-induced cancers.
Peer reviews and critiques of group projects, emphasizing data interpretation and presentation skills.

Participant’s Eligibility

Biotech, Pharma, and Life Sciences graduates
Post-graduates specializing in virology, oncology, or immunology
Academicians researching cancer viruses
Industry professionals seeking to advance their knowledge in viral oncology
Anyone interested in the role of viruses in cancer development

Program Outcomes

Acquire a critical understanding of the link between viruses and cancer.
Gain insights into the latest diagnostic and therapeutic strategies for viral-associated cancers.
Identify potential career paths within the field of viral oncology research.
Stay informed about the cutting-edge advancements in oncolytic virotherapy.

Fee Structure

Standard Fee: INR ~~49,998~~ USD ~~1,300~~

Discounted Fee: INR 24999 USD 650

Certificate

Program Assessment

Comprehensive course materials
Interactive case studies
Guest lectures from leading researchers and oncologists
Networking opportunities with industry professionals and academicians
Certificate of completion

Future Career Prospects

Viral oncology is a rapidly growing field with the potential to revolutionize cancer treatment. Graduates of this program will be well-positioned to pursue rewarding careers in various sectors, including:

Pharmaceutical and biotechnology companies
Academic research institutions
Government agencies (e.g., NIH, NCI)
Contract research organizations (CROs)
Non-profit organizations focused on cancer research

Job Opportunities

Viral Oncology researcher
Cancer Virologist
Diagnostic Scientist
Clinical research associate
Drug discovery scientist
Bioinformatics analyst
Regulatory affairs specialist
Science Communicator

Viral Oncology: Understanding Cancer Viruses

Batches

Program Aim